Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study

por Yaxley, William John, Gianduzzo, Troy, Kua, Boon, Oxford, Rachel, Yaxley, John William
Publicado 2022

Corrigendum: Correction of the Abstract. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study

por Yaxley, William John, Gianduzzo, Troy, Kua, Boon, Oxford, Rachel, Yaxley, John William
Publicado 2022

Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?

por Yaxley, William John, McBean, Rhiannon, Wong, David, Grimes, David, Vasey, Paul, Frydenberg, Mark, Yaxley, John William
Publicado 2021

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years

por Yaxley, William John, Mackean, James, Desai, Devang J., Tsang, Gail, Dixon, Judi, Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Gardiner, Robert A., Yaxley, John William
Publicado 2022